Centers & Specialties

Cancer Center

Clinical Interests
  • Prostate cancer
  • Bladder cancer
  • Testicular, penile and genito-urinary cancers
  • Renal Cancer
  • Translational research
Medical Education
  • MD, PhD, Albert Einstein College of Medicine
  • Residency, Massachusetts General Hospital
  • Fellowship, Dana Farber Cancer Institute
Board Certifications
  • Medical Oncology
  • Boston: Massachusetts General Hospital
Insurances Accepted
  • Aetna Health Inc.
  • AllWays Health (NHP) - ACD
  • AllWays Health (NHP) - PBO
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • BMC HealthNet Mass Health MCO/ACO
  • Cigna (PAL #'s)
  • Commonwealth Care Alliance
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • Maine Community Health Options (MCHO)
  • MassHealth
  • Medicare
  • Medicare - ACD
  • OSW - Connecticut
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Rhode Island
  • OSW - Vermont
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Railroad Medicare - ACD
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
  • Well Sense Pediatrics

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Patient Age Group
Provider Gender


After completing a bachelor's and a master's degree at Harvard, Dr. Lee then completed his medical school (M.D.) and graduate school (Ph.D.) training at the Albert Einstein College of Medicine, in the Bronx, New York. He came to MGH for internal medicine residency training and then completed medical oncology fellowship training through the Dana-Farber Cancer Institute / MGH joint program. During that time, he performed basic science research at the Whitehead Institute of MIT.

Research & Publications

Research Summary
Since joining the staff at MGH, Dr. Lee has been engaged in translational studies of circulating tumor cells (CTCs) from peripheral blood, using a new technology developed at MGH. Our hope is that this "CTC-Chip" may have clinical usefulness for cancer patients. In addition to seeing patients, Dr. Lee is also interested in clinical trials of new drugs to treat genitourinary cancers.


55 Fruit Street
Boston, MA 02114-2696
Phone: 617-724-4000
Fax: 617-726-8685